Skip to main content

This job has expired

You will need to login before you can apply for a job.

Vice President, Genome Engineering

Employer
Mammoth Biosciences
Location
Brisbane, CA, United States
Start date
Feb 24, 2021

View more

Discipline
Science/R&D, Genomics
Required Education
Doctorate/PHD/MD
Position Type
Full time
Hotbed
Biotech Bay

Job Details

Mammoth Biosciences, Inc. is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. By leveraging its internal research and development and exclusive licensing to patents related to Cas12, Cas13, Cas14 and CasPhi, Mammoth Biosciences can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Mammoth is democratizing disease detection with easy and affordable point-of-care tests that allow real-time and simultaneous detection of multiple conditions, along with high-throughput tests that allow for unprecedented testing volume. Further, the company is transforming disease treatment with its proprietary micro-sized CRISPR proteins that enable new editing and delivery options. Based in Brisbane, CA, Mammoth Biosciences is co-founded by CRISPR pioneer and Nobel Prize winner Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Decheng, Mayfield, NFX, and 8VC, and leading individual investors including Brook Byers, Tim Cook, Bob Nelsen, and Jeff Huber.

DESCRIPTION

Mammoth is seeking a VP of Genome Engineering that will be responsible for driving Mammoth next-generation CRISPR proteins from discovery to clinical development. The role will involve managing the genome engineering team while also being the main point of contact between external research partners and CROs. The person will work closely with company leadership to set research priorities. A deep understanding of quality, manufacturing and regulatory processes in gene editing is essential.

KEY RESPONSIBILITIES
    • Lead research and pre-clinical development aspects of Mammoth's genome engineering portfolio
    • Lead genome engineering animal studies utilizing Mammoth's CRISPR portfolio
    • Recruit and coach technical team leads to form a strong and cohesive unit
    • Oversee and manage the technical relationships with external partners
    • Work with the business development team to gather, organize, and prioritize R&D efforts
    • Plan and coordinate the creation of new genome engineering modalities
    • Implement project management approaches
    • Project budgeting and scope management
    • Work with operations in the scale up of materials and processes (with external partners as appropriate)
    • Play a strong supporting role in development and maintenance of quality system and regulatory planning
    • Proactively identify potential risks/issues and work with the team to develop mitigation strategies.
    • Work with scientific advisory board and KOLs to refine R&D strategy


REQUIRED QUALIFICATIONS
    • MD or PhD
    • Minimum of 10 years professional experience in clinical development of gene therapies or genome engineering technologies
    • Experience leading IND submission of gene editing or gene therapy product
    • Extensive experience building and managing teams


BENEFITS
    • Company-paid health/vision/dental benefits
    • Unlimited vacation and generous sick time
    • Company-sponsored meals and snacks
    • Wellness, caregiver and ergonomics benefits
    • 401(k) with company matching

Company

Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term curative therapies, as well as other applications such as decentralized precision diagnostics. Founded by CRISPR pioneer and Nobel laureate Jennifer Doudna and Trevor Martin, Janice Chen, and Lucas Harrington, the company’s ultracompact proteins are designed to enable in vivo gene editing in difficult to reach tissues utilizing both nuclease applications and new editing modalities beyond double stranded breaks, including base editing, gene writing, and epigenetic editing. The company is building out its pipeline of potential in vivo gene editing therapeutics and capabilities and has partnerships with leading pharmaceutical and biotechnology companies to broaden the reach of its innovative and proprietary technology. Mammoth’s deep science and industry experience, along with a robust and differentiated intellectual property portfolio, have enabled the company to further its mission to transform the lives of patients and deliver on the full promise of CRISPR technologies.

Facebook  Twitter  Instagram

Company info
Website
Phone
(650) 294-8583
Location
South San Francisco
CA
94080
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert